Rolvedon 82497-0132
Generic: Eflapegrastim-Xnst
Product NDC
82497-0132- Manufacturer
- Assertio Specialty Pharmaceuticals, Llc
- Dosage Form
- Injection, Solution
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- December 11, 2025
- Listing Expires
- December 31, 2027
- Application
- BLA761148
Need to source Rolvedon? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Eflapegrastim | 13.2 mg/.6mL |
Drug Class
Leukocyte Growth Factor [EPC]Granulocyte Colony-Stimulating Factor [CS]Increased Myeloid Cell Production [PE]
Packaging Options(1)
.6 mL in 1 SYRINGE, GLASS (82497-132-01)